Entropy Neurodynamics Limited
ENP
Rankning i aktier
#26199
Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical... Entropy Neurodynamics Limited operates as a clinical-stage pharmaceutical company, dedicated to pioneering novel formulations for psilocin administration. These formulations are intended for use alongside psychotherapy, aiming to tackle medical conditions with pressing unmet needs across Australia, Canada, Switzerland, and the United States. The firm's flagship development is TRP-8803, an intravenously infused psilocin formulation that has successfully concluded Phase 2 clinical trials. These trials investigated its potential to treat binge eating disorder, fibromyalgia, irritable bowel syndrome, abdominal pain, and visceral tenderness. Additionally, the company is advancing TRP-8802, a synthetic, orally administered psilocybin compound. TRP-8802 is currently undergoing Phase 2a clinical trials for binge eating and is in Phase 2 clinical development for fibromyalgia and irritable bowel syndrome. Established in 2019 and headquartered in Camberwell, Australia, the company adopted its current name, Entropy Neurodynamics Limited, in November 2025, having previously operated as Tryptamine Therapeutics Limited.
Aktiekurs
$0.02468497
Senast synkroniserad: 2026-07-30
Marknadsvärde
$40.28M
Förändring (1 dag)
0.00%
Förändring (1 år)
-56.08%
Land
AU
Handel Entropy Neurodynamics Limited (ENP)
Kategori
Healthcare
EPS för Entropy Neurodynamics Limited (ENP)
EPS per 2026 TTM: 0
Enligt Entropy Neurodynamics Limiteds senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) 0. Vid slutet av 2026 hade bolaget ett EPS på 0, lika med EPS från 2026 som var 0.
EPS-historik för Entropy Neurodynamics Limited från 2026 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | ||
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| - | - |
CH
|
|
| $27.74 | - |
NL
|
